References
- Cann A J, Chen I SY. Human T-cell leukemia virus types I and II. Virology, 2nd edn, B N Fields, D M Knipe, R M Chanock, M S Hirsch, J L Melnick, T P Monath, B Roizman. Raven Press, New York 1990; 1501–1527
- Robert-Guroff M, Weiss S H, Giron J A, Jennings A M, Ginzburg H M, Margolis I B, Blattner W A, Gallo R C. Prevalence of antibodies to HTLV-I,-II and-III in intravenous drug abusers from an AIDS endemic region. JAMA 1986; 255: 3133–3137
- Mayer V, Ebbesen P. HTLV-1 virus in Europeans: the continuous spread. A meta-analysis. Acta Virol 1991; 35: 472–495
- Zanetti A R, Zehender G, Tanzi E, Galli C, Rezza G, Cargnel A, Boschini A, Mari D, Pizzocolo G, Mazzotta F. HTLV-II among Italian intravenous drug users and hemophiliacs. Eur J Epidemiol 1992; 8: 702–707
- Blomberg J, Fäldt R. Antibodies to human adult T cell leukemia virus type I associated antigens in Swedish leukaemia patients and blood donors. Br J Haematol 1985; 60: 555–557
- Blomberg J, Moestrup T, Frimand J, Hansson B G, Krogsgaard K, Grillner L, Nordenfelt E. HTLV-I and-II in intravenous drug users from Sweden and Denmark. Scand J Infect Dis 1994; 26: 23–26
- Holm-Samdahl H, Haukenes G, Kalland K H. HTLV-infeksjon i Norge [HTLV infection in Norway]. MSIS rapport 1993; 21: 1
- Blomberg J, Robert-Guroff M, Blattner W A, Pipkorn R. Type-and group-specific continuous antigenic determinants of HTLV Use of synthetic peptides for serotyping of HTLV-I and-II infection. J Acquir Immune Defic Syndr 1992; 5: 294–302
- World Health Organization. proposed WHO criteria for interpreting results from Western Blot assays for HIV-1, HIV-2 and HTLV-I/HTLV-II. Wkly Epidemiol Rec 1990; 65: 281–288
- Page J B, Lai S H, Chitwood D D, Klimas N G, Smith P C, Fletcher M A. HTLV-I/II seropositivity and death from AIDS among HIV-1 seropositive intravenous drug users. Lancet 1990; 16: 1439–1441
- Pierik L T, Murphy E L. The clinical significance of HTLV-I and HIV-1 in the AIDS epidemic. AIDS Clin Rev 1991; 1991: 39–57
- Ryberg B, Blomberg J, Klasse P J. Tropical spastic paraparesis associated with human T lymphotropic virus type I in an East African naturalised in Sweden. BMJ 1987; 295: 1380–1381
- Harrington W J, Jr, Sheremata W, Hjelle B, Dube D K, Bradshaw P, Foung S K, Snodgrass S, Toedter G, Cabral L, Poiesz B. Spastic ataxia associated with human T-cell lymphotropic virus type II infection. Ann Neurol 1993; 33: 411–414